Eyenovia to Present at Two Upcoming Investor Conferences
September 03 2019 - 8:30AM
Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic
biopharmaceutical company developing a pipeline of microdose
therapeutics utilizing its patented piezo-print delivery
technology, today announced that Dr. Sean Ianchulev, Eyenovia’s
Chief Executive Officer and Chief Medical Officer and John
Gandolfo, Eyenovia’s Chief Financial Officer, are scheduled to
present at the 21st Annual H.C. Wainwright 21st Annual Global
Investment Conference being held on September 8-10, 2019 and the
Ladenburg Thalmann 2019 Healthcare Conference being held on
September 24, 2019 in New York.
Details for the presentations are below:
Event: H.C. Wainwright 21st
Annual Global Investment ConferenceDate: Tuesday,
September 10, 2019Time: 5:05 – 5:30pm
ETLocation: Lotte New York Palace
HotelRoom: Kennedy I (4th Floor)
Event: Ladenburg Thalmann 2019
Healthcare ConferenceDate: Tuesday, September 24,
2019Time: 2:00 – 2:25pm
ETLocation: Sofitel New YorkRoom:
Track 5 - Montmartre
A live webcast of the Company’s presentation at
the H.C. Wainwright 21st Annual Global Investment Conference may be
accessed on the Company's website at www.eyenovia.com. The webcast
will be archived for 90 days following the live presentation on the
Company's website.
Eyenovia’s management team will also be available for one-on-one
meetings with investors who are registered to attend the events.
Alternatively, interested investors may contact Tram Bui of The
Ruth Group at tbui@theruthgroup.com or (646) 536-7035 to
schedule a meeting.
About EyenoviaEyenovia, Inc.
(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical
company developing a pipeline of microdose therapeutics utilizing
its patent piezo-print delivery technology. Eyenovia’s pipeline is
currently focused on the late-stage development of microdosed
medications for mydriasis, myopia progression, glaucoma and other
eye diseases. For more information please visit
www.eyenovia.com.
Company Contact:Eyenovia,
Inc.John GandolfoChief Financial
Officerjgandolfo@eyenoviabio.com
Investor Contact:Tram Bui /
Alexander LoboThe Ruth GroupPhone:
646-536-7035/7037tbui@theruthgroup.com / alobo@theruthgroup.com
Media Contact:The Ruth
GroupKirsten Thomas508-280-6592kthomas@theruthgroup.com
Eyenovia (NASDAQ:EYEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eyenovia (NASDAQ:EYEN)
Historical Stock Chart
From Sep 2023 to Sep 2024